Skip to main content

Table 1 Demographic, histopathologic, and grading characteristics of evaluated samples

From: Characterization of immune checkpoints expression and lymphocyte densities of iranian breast cancer patients; the co-expression status and clinicopathological associates

Variable

N

%

Variable

N

%

Age, year

  

Tubule formation

  

Mean ± SD

50.33 ± 11.36

 

I

19

5.26

Median (IQR)

49 (15)

 

II

147

40.72

Tumor size

  

III

195

54.02

Mean ± SD

3.33 ± 1.75

 

Overall grade

  

Median (IQR)

3 (2)

 

I

61

16.90

Surgery type

  

II

190

52.63

Lumpectomy

75

20.78

III

110

30.47

Mastectomy

69

19.11

LV invasion

  

Missing

217

60.11

Negative

70

19.39

Nuclear grade

  

Positive

291

80.61

I

12

3.32

LN involvement

  

II

214

59.28

Negative

157

43.49

III

135

37.40

Positive

204

56.51

Mitotic grade

     

I

135

37.40

   

II

138

38.23

   

III

88

24.38

   
  1. LN, lymph node; LV, Lymphovascular